193 related articles for article (PubMed ID: 38002285)
1. Targeting the Structural Maturation Pathway of HIV-1 Reverse Transcriptase.
Kirby TW; Gabel SA; DeRose EF; Perera L; Krahn JM; Pedersen LC; London RE
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002285
[TBL] [Abstract][Full Text] [Related]
2. Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.
Zheng X; Mueller GA; Cuneo MJ; Derose EF; London RE
Biochemistry; 2010 Apr; 49(13):2821-33. PubMed ID: 20180596
[TBL] [Abstract][Full Text] [Related]
3. Selective unfolding of one Ribonuclease H domain of HIV reverse transcriptase is linked to homodimer formation.
Zheng X; Pedersen LC; Gabel SA; Mueller GA; Cuneo MJ; DeRose EF; Krahn JM; London RE
Nucleic Acids Res; 2014 Apr; 42(8):5361-77. PubMed ID: 24574528
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation.
Sluis-Cremer N; Arion D; Abram ME; Parniak MA
Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348
[TBL] [Abstract][Full Text] [Related]
5. Unfolding the HIV-1 reverse transcriptase RNase H domain--how to lose a molecular tug-of-war.
Zheng X; Pedersen LC; Gabel SA; Mueller GA; DeRose EF; London RE
Nucleic Acids Res; 2016 Feb; 44(4):1776-88. PubMed ID: 26773054
[TBL] [Abstract][Full Text] [Related]
6. Identification of drivers for the metamorphic transition of HIV-1 reverse transcriptase.
Zheng X; Mueller GA; Kim K; Perera L; DeRose EF; London RE
Biochem J; 2017 Sep; 474(19):3321-3338. PubMed ID: 28811321
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine.
Sluis-Cremer N; Dmitrienko GI; Balzarini J; Camarasa MJ; Parniak MA
Biochemistry; 2000 Feb; 39(6):1427-33. PubMed ID: 10684624
[TBL] [Abstract][Full Text] [Related]
8. Spatial domain organization in the HIV-1 reverse transcriptase p66 homodimer precursor probed by double electron-electron resonance EPR.
Schmidt T; Schwieters CD; Clore GM
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17809-17816. PubMed ID: 31383767
[TBL] [Abstract][Full Text] [Related]
9. Relative domain orientation of the L289K HIV-1 reverse transcriptase monomer.
Xi Z; Ilina TV; Guerrero M; Fan L; Sluis-Cremer N; Wang YX; Ishima R
Protein Sci; 2022 May; 31(5):e4307. PubMed ID: 35481647
[TBL] [Abstract][Full Text] [Related]
10. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
[TBL] [Abstract][Full Text] [Related]
11. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC
J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
[TBL] [Abstract][Full Text] [Related]
12. Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase.
Venezia CF; Howard KJ; Ignatov ME; Holladay LA; Barkley MD
Biochemistry; 2006 Mar; 45(9):2779-89. PubMed ID: 16503633
[TBL] [Abstract][Full Text] [Related]
13. Probing the Interaction between HIV-1 Protease and the Homodimeric p66/p66' Reverse Transcriptase Precursor by Double Electron-Electron Resonance EPR Spectroscopy.
Schmidt T; Louis JM; Clore GM
Chembiochem; 2020 Nov; 21(21):3051-3055. PubMed ID: 32558168
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.
Wang J; Smerdon SJ; Jäger J; Kohlstaedt LA; Rice PA; Friedman JM; Steitz TA
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7242-6. PubMed ID: 7518928
[TBL] [Abstract][Full Text] [Related]
15. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.
Schuckmann MM; Marchand B; Hachiya A; Kodama EN; Kirby KA; Singh K; Sarafianos SG
J Biol Chem; 2010 Dec; 285(49):38700-9. PubMed ID: 20876531
[TBL] [Abstract][Full Text] [Related]
16. Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: a two step process.
Divita G; Rittinger K; Geourjon C; Deléage G; Goody RS
J Mol Biol; 1995 Feb; 245(5):508-21. PubMed ID: 7531247
[TBL] [Abstract][Full Text] [Related]
17. Efavirenz binding site in HIV-1 reverse transcriptase monomers.
Braz VA; Barkley MD; Jockusch RA; Wintrode PL
Biochemistry; 2010 Dec; 49(49):10565-73. PubMed ID: 21090588
[TBL] [Abstract][Full Text] [Related]
18. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
Balzarini J; Auwerx J; Rodríguez-Barrios F; Chedad A; Farkas V; Ceccherini-Silberstein F; García-Aparicio C; Velázquez S; De Clercq E; Perno CF; Camarasa MJ; Gago F
Mol Pharmacol; 2005 Jul; 68(1):49-60. PubMed ID: 15833734
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.
Grohmann D; Corradi V; Elbasyouny M; Baude A; Horenkamp F; Laufer SD; Manetti F; Botta M; Restle T
Chembiochem; 2008 Apr; 9(6):916-22. PubMed ID: 18318036
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric conformational maturation of HIV-1 reverse transcriptase.
Zheng X; Perera L; Mueller GA; DeRose EF; London RE
Elife; 2015 Jun; 4():. PubMed ID: 26037594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
